Wells Fargo & Company Pardes Biosciences, Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$1.4 - $1.95 $8,415 - $11,721	-6,011 Reduced 97.55%	151 $0
Q1 2023 May 12, 2023	BUY	$1.21 - $2.22 $7,274 - $13,346	6,012 Added 4008.0%	6,162 $8,000
Q4 2022 Feb 13, 2023	SELL	$0.85 - $1.69 $1 - $3	-2 Reduced 1.32%	150 $0
Q3 2022 Nov 14, 2022	SELL	$2.14 - $3.7 $761 - $1,317	-356 Reduced 70.08%	152 $0
Q2 2022 Aug 12, 2022	BUY	$2.84 - $8.57 $525 - $1,585	185 Added 57.28%	508 $1,000
Q1 2022 May 16, 2022	SELL	$5.64 - $15.64 $106,844 - $296,284	-18,944 Reduced 98.32%	323 $2,000
Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $188,816 - $327,924	19,267 New	19,267 $315,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.